MB-110

Microbio Co Ltd · Phase 1 active Small molecule

At a glance

Generic name	MB-110
Also known as	DBPR110, NSFA10003S0
Sponsor	Microbio Co Ltd
Modality	Small molecule
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

A Trial to Evaluate Safety, Tolerability, PK and Antiviral Activity of MB-110 in Hepatitis C Virus Infected Patients (PHASE1)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

MB-110 CI brief — competitive landscape report
MB-110 updates RSS · CI watch RSS
Microbio Co Ltd portfolio CI